Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.

NCT00255645 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00255645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00255645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-Term, Post-Treatment, Safety Follow-Up, Multi-Center Study in Patients With Type 2 Diabetes Mellitus From the GALLANT, GALLEX or ARMOR Studies.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Terminated
Start date
September 30, 2005
Completion date
December 31, 2006
Enrollment
4,500
Sites
543

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes